Evidence map›Paper›PMID 36741250›Full record

ArticleSensors & diagnostics2023

Real-time, smartphone-based processing of lateral flow assays for early failure detection and rapid testing workflows.

Monika Colombo, Léonard Bezinge, Andres Rocha Tapia, Chih-Jen Shih, Andrew J de Mello, Daniel A Richards

Erratum issuedAbstract read
In one paragraph

Article in Sensors & diagnostics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Monika ColomboInstitute for Chemical and Bioengineering, ETH Zurich Vladimir-Prelog-Weg 1 8093 Zürich Switzerland andrew.demello@chem.ethz.ch daniel.richards@chem.ethz.ch.ORCID https://orcid.org/0000-0002-6658-4438
Léonard BezingeInstitute for Chemical and Bioengineering, ETH Zurich Vladimir-Prelog-Weg 1 8093 Zürich Switzerland andrew.demello@chem.ethz.ch daniel.richards@chem.ethz.ch.ORCID https://orcid.org/0000-0002-9733-9697
Andres Rocha TapiaInstitute for Chemical and Bioengineering, ETH Zurich Vladimir-Prelog-Weg 1 8093 Zürich Switzerland andrew.demello@chem.ethz.ch daniel.richards@chem.ethz.ch.ORCID https://orcid.org/0000-0001-7236-6042
Chih-Jen ShihInstitute for Chemical and Bioengineering, ETH Zurich Vladimir-Prelog-Weg 1 8093 Zürich Switzerland andrew.demello@chem.ethz.ch daniel.richards@chem.ethz.ch.ORCID https://orcid.org/0000-0002-5258-3485
Andrew J de MelloInstitute for Chemical and Bioengineering, ETH Zurich Vladimir-Prelog-Weg 1 8093 Zürich Switzerland andrew.demello@chem.ethz.ch daniel.richards@chem.ethz.ch.ORCID https://orcid.org/0000-0003-1943-1356
Daniel A RichardsInstitute for Chemical and Bioengineering, ETH Zurich Vladimir-Prelog-Weg 1 8093 Zürich Switzerland andrew.demello@chem.ethz.ch daniel.richards@chem.ethz.ch.ORCID https://orcid.org/0000-0001-8827-9170

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite their simplicity, lateral flow immunoassays (LFIAs) remain a crucial weapon in the diagnostic arsenal, particularly at the point-of-need. However, methods for analysing LFIAs still rely heavily on sub-optimal human readout and rudimentary end-point analysis. This negatively impacts both testing accuracy and testing times, ultimately lowering diagnostic throughput. Herein, we present an automated computational imaging method for processing and analysing multiple LFIAs in real-time and in parallel. This method relies on the automated detection of signal intensity at the test line, control line, and background, and employs statistical comparison of these values to predictively categorise tests as "positive", "negative", or "failed". We show that such a computational methodology can be transferred to a smartphone and detail how real-time analysis of LFIAs can be leveraged to decrease the time-to-result and increase testing throughput. We compare our method to naked-eye readout and demonstrate a shorter time-to-result across a range of target antigen concentrations and fewer false negatives compared to human subjects at low antigen concentrations.

Identifiers

PMID36741250
PMCPMC9850356

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.